Left ventricular assist device bridge therapy for acute myocardial infarction

Soon J. Park, Duc Q. Nguyen, Alan J. Bank, Sofia Ormaza, R. Morton Bolman

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background. Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have a high mortality rate. Current treatment modalities remain suboptimal for these patients. Methods. From April 1995 to March 1998, 7 patients were identified as having AMI associated with cardiogenic shock. All received intraaortic balloon pump assistance, in addition to maximal inotropic support. Results. The mean preoperative cardiac index was 2.0 ± 0.3 L/min/m2 and pulmonary capillary wedge pressure was 23 ± 6 mm Hg. Three patients received thrombolytic therapy and 4 patients underwent percutaneous transluminal coronary angioplasty without success. Left ventricular assist devices (LVADs) were implanted as bridge therapy to heart transplantation. One patient died from recurrence of a ventricular septal defect during LVAD support. Six patients were transplanted successfully after mean LVAD support of 59 ± 33 days. Five patients are alive and well at a mean follow-up of 898 ± 447 days. One patient died 3 days after transplantation from acute allograft dysfunction. Conclusions. Timely application of LVADs as bridge therapy to heart transplantation in these critically ill patients can be lifesaving, and should be investigated further. (C) 2000 by The Society of Thoracic Surgeons.

Original languageEnglish (US)
Pages (from-to)1146-1151
Number of pages6
JournalAnnals of Thoracic Surgery
Volume69
Issue number4
DOIs
StatePublished - Apr 2000
Externally publishedYes

Fingerprint

Heart-Assist Devices
Myocardial Infarction
Therapeutics
Cardiogenic Shock
Heart Transplantation
Pulmonary Wedge Pressure
Coronary Balloon Angioplasty
Ventricular Heart Septal Defects
Thrombolytic Therapy
Critical Illness
Allografts
Transplantation
Recurrence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Park, S. J., Nguyen, D. Q., Bank, A. J., Ormaza, S., & Bolman, R. M. (2000). Left ventricular assist device bridge therapy for acute myocardial infarction. Annals of Thoracic Surgery, 69(4), 1146-1151. https://doi.org/10.1016/S0003-4975(99)01575-1

Left ventricular assist device bridge therapy for acute myocardial infarction. / Park, Soon J.; Nguyen, Duc Q.; Bank, Alan J.; Ormaza, Sofia; Bolman, R. Morton.

In: Annals of Thoracic Surgery, Vol. 69, No. 4, 04.2000, p. 1146-1151.

Research output: Contribution to journalArticle

Park, Soon J. ; Nguyen, Duc Q. ; Bank, Alan J. ; Ormaza, Sofia ; Bolman, R. Morton. / Left ventricular assist device bridge therapy for acute myocardial infarction. In: Annals of Thoracic Surgery. 2000 ; Vol. 69, No. 4. pp. 1146-1151.
@article{8aa57806cbd34d7db3601dbb7a09abdc,
title = "Left ventricular assist device bridge therapy for acute myocardial infarction",
abstract = "Background. Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have a high mortality rate. Current treatment modalities remain suboptimal for these patients. Methods. From April 1995 to March 1998, 7 patients were identified as having AMI associated with cardiogenic shock. All received intraaortic balloon pump assistance, in addition to maximal inotropic support. Results. The mean preoperative cardiac index was 2.0 ± 0.3 L/min/m2 and pulmonary capillary wedge pressure was 23 ± 6 mm Hg. Three patients received thrombolytic therapy and 4 patients underwent percutaneous transluminal coronary angioplasty without success. Left ventricular assist devices (LVADs) were implanted as bridge therapy to heart transplantation. One patient died from recurrence of a ventricular septal defect during LVAD support. Six patients were transplanted successfully after mean LVAD support of 59 ± 33 days. Five patients are alive and well at a mean follow-up of 898 ± 447 days. One patient died 3 days after transplantation from acute allograft dysfunction. Conclusions. Timely application of LVADs as bridge therapy to heart transplantation in these critically ill patients can be lifesaving, and should be investigated further. (C) 2000 by The Society of Thoracic Surgeons.",
author = "Park, {Soon J.} and Nguyen, {Duc Q.} and Bank, {Alan J.} and Sofia Ormaza and Bolman, {R. Morton}",
year = "2000",
month = "4",
doi = "10.1016/S0003-4975(99)01575-1",
language = "English (US)",
volume = "69",
pages = "1146--1151",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Left ventricular assist device bridge therapy for acute myocardial infarction

AU - Park, Soon J.

AU - Nguyen, Duc Q.

AU - Bank, Alan J.

AU - Ormaza, Sofia

AU - Bolman, R. Morton

PY - 2000/4

Y1 - 2000/4

N2 - Background. Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have a high mortality rate. Current treatment modalities remain suboptimal for these patients. Methods. From April 1995 to March 1998, 7 patients were identified as having AMI associated with cardiogenic shock. All received intraaortic balloon pump assistance, in addition to maximal inotropic support. Results. The mean preoperative cardiac index was 2.0 ± 0.3 L/min/m2 and pulmonary capillary wedge pressure was 23 ± 6 mm Hg. Three patients received thrombolytic therapy and 4 patients underwent percutaneous transluminal coronary angioplasty without success. Left ventricular assist devices (LVADs) were implanted as bridge therapy to heart transplantation. One patient died from recurrence of a ventricular septal defect during LVAD support. Six patients were transplanted successfully after mean LVAD support of 59 ± 33 days. Five patients are alive and well at a mean follow-up of 898 ± 447 days. One patient died 3 days after transplantation from acute allograft dysfunction. Conclusions. Timely application of LVADs as bridge therapy to heart transplantation in these critically ill patients can be lifesaving, and should be investigated further. (C) 2000 by The Society of Thoracic Surgeons.

AB - Background. Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have a high mortality rate. Current treatment modalities remain suboptimal for these patients. Methods. From April 1995 to March 1998, 7 patients were identified as having AMI associated with cardiogenic shock. All received intraaortic balloon pump assistance, in addition to maximal inotropic support. Results. The mean preoperative cardiac index was 2.0 ± 0.3 L/min/m2 and pulmonary capillary wedge pressure was 23 ± 6 mm Hg. Three patients received thrombolytic therapy and 4 patients underwent percutaneous transluminal coronary angioplasty without success. Left ventricular assist devices (LVADs) were implanted as bridge therapy to heart transplantation. One patient died from recurrence of a ventricular septal defect during LVAD support. Six patients were transplanted successfully after mean LVAD support of 59 ± 33 days. Five patients are alive and well at a mean follow-up of 898 ± 447 days. One patient died 3 days after transplantation from acute allograft dysfunction. Conclusions. Timely application of LVADs as bridge therapy to heart transplantation in these critically ill patients can be lifesaving, and should be investigated further. (C) 2000 by The Society of Thoracic Surgeons.

UR - http://www.scopus.com/inward/record.url?scp=0034096778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034096778&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(99)01575-1

DO - 10.1016/S0003-4975(99)01575-1

M3 - Article

C2 - 10800809

AN - SCOPUS:0034096778

VL - 69

SP - 1146

EP - 1151

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -